In developing countries, over half a million children die from rotavirus every year. Another two million children are severely sickened and hospitalized by the disease. Rotavirus is the most common cause of diarrheal hospitalizations and deaths among children worldwide. Development of a rotavirus vaccine has been a global health priority for many years, and with two vaccines currently on the market, the promise of prevention is now becoming reality in several parts of the world.
Sabin is currently working to facilitate the introduction of a rotavirus vaccine in targeted areas across the globe. In 2003, Sabin launched a rotavirus advocacy initiative to call attention to this disease and its impact. Every other year Sabin has co-hosted meetings that bring together scientists, clinicians, public health professionals, immunization leaders, vaccine industry representatives and donors to share the latest research and assist in the development of strategies to make rotavirus vaccines available to children around the world.